Analyst calls this week: Broadcom, Moderna and Abbott among top picks
Seeking Alpha recaps the week: D.A. Davidson upgraded Broadcom, William Blair downgraded Moderna, and Argus cut Abbott to Hold after a growth outlook cut.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to Seeking Alpha, the S&P 500 closed lower on Friday as investors digested quarterly reports from large companies, including Alphabet and Microsoft. During the week, Wall Street analysts issued a series of upgrades and downgrades.
D.A. Davidson raised Broadcom to Buy from Neutral and lifted its price target to $400 from $350. Analyst Gil Luria argues that at 16 times 2027 earnings the stock prices in almost no chance of the Anthropic and OpenAI IPOs happening. William Blair cut Moderna to Market Perform, citing valuation after the shares rose 545% so far this year. Argus Research lowered Abbott to Hold from Buy after the company trimmed its full-year comparable sales growth outlook to about 6%.
Jefferies upgraded Rivian to Buy from Hold, GF Securities raised its AMD price target to $720, and J.P. Morgan moved Constellium up to Overweight from Neutral with a $35 price target.
why it matters
For the market, such rating changes are routine and mainly affect individual stocks. Taken together, however, they show how analysts are weighing expectations for AI, biotech and industrial companies after third-quarter reports. This material is for information only and is not investment advice.
tags
instruments
sources
- Notable analyst calls this week: Broadcom, Moderna and Abbott among top picks — Seeking Alpha, 31 October 2026 at 14:05 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗